New Change To Liabilities vs Change Receivables Analysis

NYT Stock  USD 54.16  0.91  1.71%   
New York financial indicator trend analysis is infinitely more than just investigating New York Times recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether New York Times is a good investment. Please check the relationship between New York Change To Liabilities and its Change Receivables accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in New York Times. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Change To Liabilities vs Change Receivables

Change To Liabilities vs Change Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of New York Times Change To Liabilities account and Change Receivables. At this time, the significance of the direction appears to have weak relationship.
The correlation between New York's Change To Liabilities and Change Receivables is 0.38. Overlapping area represents the amount of variation of Change To Liabilities that can explain the historical movement of Change Receivables in the same time period over historical financial statements of New York Times, assuming nothing else is changed. The correlation between historical values of New York's Change To Liabilities and Change Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Liabilities of New York Times are associated (or correlated) with its Change Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change Receivables has no effect on the direction of Change To Liabilities i.e., New York's Change To Liabilities and Change Receivables go up and down completely randomly.

Correlation Coefficient

0.38
Relationship DirectionPositive 
Relationship StrengthVery Weak

Change To Liabilities

Change Receivables

The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.
Most indicators from New York's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into New York Times current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in New York Times. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
At this time, New York's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 20.59 in 2024, whereas Tax Provision is likely to drop slightly above 52.9 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense769K40.7M1.0M963.3K
Depreciation And Amortization67.0M92.6M95.3M94.5M

New York fundamental ratios Correlations

0.180.250.590.220.67-0.150.440.420.760.290.350.87-0.510.330.00.53-0.820.670.640.580.0-0.02-0.13-0.320.09
0.18-0.66-0.29-0.820.620.78-0.590.33-0.01-0.640.420.08-0.260.95-0.18-0.47-0.40.77-0.30.50.51-0.25-0.79-0.160.25
0.25-0.660.190.73-0.17-0.580.51-0.160.490.62-0.490.29-0.2-0.580.10.790.12-0.350.69-0.4-0.630.470.590.41-0.16
0.59-0.290.190.490.14-0.230.59-0.110.510.440.070.62-0.1-0.270.420.43-0.370.120.520.180.20.030.2-0.210.06
0.22-0.820.730.49-0.42-0.790.910.00.360.84-0.080.150.32-0.730.280.74-0.01-0.570.66-0.1-0.380.120.67-0.08-0.19
0.670.62-0.170.14-0.420.35-0.170.350.56-0.210.160.73-0.620.74-0.290.12-0.670.880.20.390.08-0.22-0.33-0.140.13
-0.150.78-0.58-0.23-0.790.35-0.68-0.33-0.05-0.66-0.04-0.09-0.130.650.07-0.56-0.080.48-0.410.00.57-0.13-0.660.130.26
0.44-0.590.510.590.91-0.17-0.680.180.480.80.210.30.36-0.450.250.71-0.37-0.320.660.22-0.19-0.180.51-0.41-0.14
0.420.33-0.16-0.110.00.35-0.330.180.060.090.710.19-0.060.44-0.320.14-0.430.360.180.75-0.08-0.22-0.2-0.42-0.05
0.76-0.010.490.510.360.56-0.050.480.060.4-0.150.78-0.310.150.120.75-0.560.370.820.06-0.260.080.110.080.08
0.29-0.640.620.440.84-0.21-0.660.80.090.40.040.190.32-0.50.30.64-0.02-0.390.620.04-0.42-0.090.65-0.16-0.41
0.350.42-0.490.07-0.080.16-0.040.210.71-0.150.04-0.010.230.47-0.1-0.23-0.560.36-0.110.960.44-0.56-0.36-0.83-0.06
0.870.080.290.620.150.73-0.090.30.190.780.19-0.01-0.640.22-0.040.5-0.60.620.650.26-0.10.07-0.01-0.050.27
-0.51-0.26-0.2-0.10.32-0.62-0.130.36-0.06-0.310.320.23-0.64-0.280.21-0.120.23-0.67-0.160.00.14-0.490.26-0.34-0.2
0.330.95-0.58-0.27-0.730.740.65-0.450.440.15-0.50.470.22-0.28-0.27-0.33-0.550.84-0.180.570.33-0.37-0.7-0.260.17
0.0-0.180.10.420.28-0.290.070.25-0.320.120.3-0.1-0.040.21-0.270.250.07-0.210.23-0.090.040.220.090.140.02
0.53-0.470.790.430.740.12-0.560.710.140.750.64-0.230.5-0.12-0.330.25-0.29-0.120.87-0.09-0.550.270.520.16-0.09
-0.82-0.40.12-0.37-0.01-0.67-0.08-0.37-0.43-0.56-0.02-0.56-0.60.23-0.550.07-0.29-0.68-0.34-0.71-0.260.390.290.64-0.14
0.670.77-0.350.12-0.570.880.48-0.320.360.37-0.390.360.62-0.670.84-0.21-0.12-0.680.040.560.29-0.12-0.62-0.210.22
0.64-0.30.690.520.660.2-0.410.660.180.820.62-0.110.65-0.16-0.180.230.87-0.340.040.05-0.390.250.320.120.23
0.580.5-0.40.18-0.10.390.00.220.750.060.040.960.260.00.57-0.09-0.09-0.710.560.050.41-0.49-0.4-0.780.01
0.00.51-0.630.2-0.380.080.57-0.19-0.08-0.26-0.420.44-0.10.140.330.04-0.55-0.260.29-0.390.41-0.32-0.56-0.410.2
-0.02-0.250.470.030.12-0.22-0.13-0.18-0.220.08-0.09-0.560.07-0.49-0.370.220.270.39-0.120.25-0.49-0.32-0.080.780.19
-0.13-0.790.590.20.67-0.33-0.660.51-0.20.110.65-0.36-0.010.26-0.70.090.520.29-0.620.32-0.4-0.56-0.080.07-0.31
-0.32-0.160.41-0.21-0.08-0.140.13-0.41-0.420.08-0.16-0.83-0.05-0.34-0.260.140.160.64-0.210.12-0.78-0.410.780.070.09
0.090.25-0.160.06-0.190.130.26-0.14-0.050.08-0.41-0.060.27-0.20.170.02-0.09-0.140.220.230.010.20.19-0.310.09
Click cells to compare fundamentals

New York Account Relationship Matchups

New York fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.1B2.3B2.6B2.5B2.7B3.1B
Short Long Term Debt Total55.1M52.7M63.6M59.1M42.9M40.8M
Other Current Liab224.9M363.6M432.1M456.6M494.6M519.3M
Total Current Liabilities437.7M486.7M559.2M571.2M611.6M664.8M
Total Stockholder Equity1.2B1.3B1.5B1.6B1.8B1.2B
Property Plant And Equipment Net627.1M594.5M575.0M611.3M549.6M780.3M
Net Debt(175.3M)(233.4M)(256.4M)(162.3M)(246.6M)(234.2M)
Retained Earnings1.6B1.7B1.8B2.0B2.1B1.5B
Cash230.4M286.1M320.0M221.4M289.5M151.2M
Non Current Assets Total1.4B1.5B1.6B1.9B1.9B1.8B
Non Currrent Assets Other239.6M319.3M360.9M300.1M266.2M223.2M
Cash And Short Term Investments432.2M595.2M661.0M347.4M451.6M265.4M
Net Receivables213.4M183.7M232.9M217.5M242.5M295.2M
Common Stock Shares Outstanding167.5M168.0M168.5M167.1M165.7M130.7M
Liabilities And Stockholders Equity2.1B2.3B2.6B2.5B2.7B3.1B
Non Current Liabilities Total477.6M492.8M464.2M362.6M339.8M322.8M
Inventory29.1M29.5M33.2M54.9M49.4M26.1M
Other Current Assets42.1M57.0M58.8M90.8M87.6M69.3M
Other Stockholder Equity36.8M45.5M58.9M(20.8M)(19.5M)(18.6M)
Total Liab915.3M979.6M1.0B933.8M951.4M1.9B
Property Plant And Equipment Gross627.1M594.5M1.4B1.4B1.4B1.1B
Total Current Assets716.8M835.8M952.7M655.7M781.7M713.4M
Accumulated Other Comprehensive Income(495.0M)(410.2M)(383.2M)(357.8M)(352.9M)(370.5M)
Short Term Debt7.9M9.1M9.1M9.9M10.1M9.6M
Intangible Assets3M9M14.2M317.3M285.5M503.4M
Accounts Payable116.6M123.2M127.1M114.6M116.9M114.0M
Good Will138.7M171.7M166.4M414.0M416.1M486.3M
Common Stock Total Equity17.4M17.5M(171.2M)17.7M15.9M16.7M
Common Stock17.5M17.6M17.7M17.7M17.8M17.5M
Other Liab422.4M440.1M400.6M303.4M273.1M259.4M
Other Assets284.9M396.6M352.0M364.1M1.00.95
Property Plant Equipment627.1M594.5M426.9M613.9M552.5M775.5M
Current Deferred Revenue88.4M105.3M119.3M96.4M172.8M154.6M
Short Term Investments201.8M309.1M341.1M126.0M162.1M280.8M
Net Tangible Assets1.2B1.3B1.3B866.6M996.6M883.6M
Retained Earnings Total Equity1.5B1.6B1.7B1.8B2.1B1.5B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for New Stock Analysis

When running New York's price analysis, check to measure New York's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New York is operating at the current time. Most of New York's value examination focuses on studying past and present price action to predict the probability of New York's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New York's price. Additionally, you may evaluate how the addition of New York to your portfolios can decrease your overall portfolio volatility.